Thubrikar Aortic Valve, Inc.: Thubrikar Aortic Valve to Pres

Thubrikar Aortic Valve, Inc., is happy to announce that results of the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV) in patients with severe aortic stenosis

Related Keywords

Philadelphia , Pennsylvania , United States , France , South Dakota , Paris , France General , New York , Brazil , Poland , Samir Wadke , Mano Thubrikar , Susheel Kodali , Mathew Williams , Jaroslaw Trebacz , Business Development , Heineman Medical Research Center , Advisors For The Company , Thubrikar Aortic Valve Inc , Langone Health , University Of Virginia , Heart Valve Center , Research Scientist At Edwards Lifesciences , Company Precision , Company Founder , Surgical Research , Presbyterian Columbia University Medical Center , Dakota School Of Mines , Structural Heart Valve Center At New York , Thubrikar Aortic Valve , Optimum Transcatheter Aortic Valve , Principal Investigator , Specialty Hospital Jana Pawla , Late Breaking Trials , Structural Heart Valve Center , Columbia University Medical Center , Medical Advisors , Aortic Valve , Biomedical Engineering , Distinguished Research Scientist , Edwards Lifesciences , South Dakota School , Vice President , Thubrikar , Aortic , Valve , Present , Romising , Nitial , Results , Park , Nabling , Study , Ith , Novel , Optimum , Uropcr , 023 ,